首页 > 最新文献

General Surgery最新文献

英文 中文
Paraesophageal hernia: the state of the problem and controversial issues. Review 食管癌旁疝的现状及争议问题。审查
Pub Date : 2022-12-30 DOI: 10.30978/gs-2022-2-83
T. Tarasov, L. Markulan
The literature review focuses on the controversial issues regarding the treatment of paraesophageal hernia. The limitations of the current classification of hiatal hernias are highlighted. It is irrelevant and does not meet clinical needs. Objective criteria for its improvement are proposed. Data on the prevalence and course of hiatal hernias are given. Their pathogenetic factors and diagnostic methods are underlined. Considerable emphasis is placed on the paraesophageal hernia treatment strategies in patients with an asymptomatic and mildly symptomatic clinical course of the disease. Arguments are presented in favour of both wait‑and‑see tactics and planned hernioplasty. The choice of hernioplasty technique, especially in the case of giant hernias, the feasibility and indications for the use of mesh implants depending on their shape and composition, and the potential complications of allogenioplasty are the main topics for discussion. The problem of selecting a fundoplication method is addressed while weighing the advantages and potential side effects of employing various fundoplication modifications. The effects of correcting a short esophagus and eliminating the axial pressure on the esophageal hiatus are thoroughly evaluated, as these conditions increase the risk of hernia recurrence. The authors concluded that there are many controversial issues in the treatment of paraesophageal hernia. A consensus is needed on the classification of paraesophageal hernias, which would meet the urgent needs of choosing the method of operative delivery, and, in particular, the definition of the concepts of «large hernia» and «giant hernia.» Further research is required on issues such as the indications for operative treatment of paraesophageal hernias, especially in the case of asymptomatic large hernias and incarcerated hernias; the feasibility of using implants for plastic surgery of the esophageal hiatus; the choice of a fundoplication method; the diagnosis and correction of a short esophagus; and methodology for evaluating long‑term treatment outcomes.  
本文就食道旁疝治疗中存在争议的问题进行综述。强调了目前裂孔疝分类的局限性。这是不相关的,不符合临床需要。提出了改进的客观标准。资料的流行和裂孔疝的过程给出。重点介绍了其发病因素和诊断方法。相当多的重点放在食管旁疝患者的治疗策略与无症状和轻度症状的临床病程的疾病。提出了支持观望策略和计划疝成形术的论点。疝成形术的选择,特别是在巨大疝的情况下,根据其形状和成分使用网状植入物的可行性和适应症,以及同种异体成形术的潜在并发症是讨论的主要主题。在权衡采用各种复底修改的优点和潜在副作用的同时,解决了选择复底方法的问题。矫正食管短段和消除食管裂孔轴向压力的效果被彻底评估,因为这些情况会增加疝复发的风险。作者认为,在食管旁疝的治疗中存在许多有争议的问题。食管旁疝的分类需要有一个共识,以满足手术方式选择的迫切需要,特别是“大疝”和“巨疝”概念的定义。»食管旁疝,特别是无症状大疝和嵌顿疝的手术治疗指征等问题有待进一步研究;种植体用于食管裂孔整形手术的可行性基础复制方法的选择;食管短的诊断与矫正评估长期治疗结果的方法学。
{"title":"Paraesophageal hernia: the state of the problem and controversial issues. Review","authors":"T. Tarasov, L. Markulan","doi":"10.30978/gs-2022-2-83","DOIUrl":"https://doi.org/10.30978/gs-2022-2-83","url":null,"abstract":"The literature review focuses on the controversial issues regarding the treatment of paraesophageal hernia. The limitations of the current classification of hiatal hernias are highlighted. It is irrelevant and does not meet clinical needs. Objective criteria for its improvement are proposed. Data on the prevalence and course of hiatal hernias are given. Their pathogenetic factors and diagnostic methods are underlined. Considerable emphasis is placed on the paraesophageal hernia treatment strategies in patients with an asymptomatic and mildly symptomatic clinical course of the disease. Arguments are presented in favour of both wait‑and‑see tactics and planned hernioplasty. The choice of hernioplasty technique, especially in the case of giant hernias, the feasibility and indications for the use of mesh implants depending on their shape and composition, and the potential complications of allogenioplasty are the main topics for discussion. The problem of selecting a fundoplication method is addressed while weighing the advantages and potential side effects of employing various fundoplication modifications. The effects of correcting a short esophagus and eliminating the axial pressure on the esophageal hiatus are thoroughly evaluated, as these conditions increase the risk of hernia recurrence. \u0000The authors concluded that there are many controversial issues in the treatment of paraesophageal hernia. A consensus is needed on the classification of paraesophageal hernias, which would meet the urgent needs of choosing the method of operative delivery, and, in particular, the definition of the concepts of «large hernia» and «giant hernia.» Further research is required on issues such as the indications for operative treatment of paraesophageal hernias, especially in the case of asymptomatic large hernias and incarcerated hernias; the feasibility of using implants for plastic surgery of the esophageal hiatus; the choice of a fundoplication method; the diagnosis and correction of a short esophagus; and methodology for evaluating long‑term treatment outcomes. \u0000 ","PeriodicalId":12661,"journal":{"name":"General Surgery","volume":"153 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78660923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ventral hernia repair surgery after abdominal gunshot wound 腹部枪伤后腹疝修补手术
Pub Date : 2022-12-30 DOI: 10.30978/gs-2022-2-29
I. Khomenko, V. Shapovalov, O. Herasymenko, R. Gybalo, R. Yenin
Gunshot wounds to the abdomen frequently result in significant damage to the abdominal organs, which is accompanied by peritonitis and the further development of different complications (anastomotic leakage, formation of abscesses, repeated bleeding, etc.), which require repeated surgical interventions that contribute to the formation of postoperative ventral hernias. The surgical management of ventral hernias is challenging due to severe adhesion in the abdominal cavity (irrespective of the time period since the injury and the last surgical interventions), the difficulties in closing massive defects of the muscle‑aponeurotic component of the anterior abdominal wall, contracture of the anterior abdominal wall, and the development of the abdominal compartment syndrome in the postoperative period. As a result, there is still some debate over the best surgical treatment for postoperative ventral hernias.Objective — to carry out a comparative analysis of open and video‑assisted laparoscopic operations for the selection of the most optimal surgical strategy for the management of ventral hernias after gunshot wounds to the abdomen.Materials and methods. We analyzed the surgical treatment of 45 wounded patients with postoperative ventral hernias that developed after operations for abdominal gunshot wounds. The patients were treated at the Military Medical Clinical Center of the Southern Region (Odesa) from 2014 to 2021; 32 of them had penetrating gunshot wounds, and 13 patients had a closed gunshot wound to the abdomen with injuries to the abdominal organs. 66.7 % of those injured had one operation on their abdominal organs, 22.2 % had two operations, 6.7 % had three operations, and 4.4 % had five operations. The size of the hernia orifices and severity of recurrence risk were determined according to the SWE classification: W1 (width of the hernia orifices up to 4 cm) — 28.9 %, W2 (from 4 to 10 cm) — 44.4 %, and W3 (over 10 cm) — 26.7 % of patients. The patients who had laparoscopic hernia repair (LHR) (IPOM‑Plus method — 17 patients, sIPOM — 2 patients) belonged to the LHR group (n = 19). The patients who had open hernia repair (OHR) (IPOM‑Plus method — 7 patients, sublay technique — 11 patients, onlay technique — 8 patients) were added to the OHR group (n = 26). The patients of both groups did not statistically differ by age, nature of a gunshot injury, number of operations before hernia repair, or hernia parameters (all p > 0.05).Results. Postoperative hernias after gunshot wounds are associated with pronounced adhesions in the abdominal cavity. The mean value of the peritoneal adhesion index averaged 11.7 ± 0.7 points (from 5 to 23 points) and did not statistically differ between groups: in the OHR group — 12.4 ± 0.9 points, in the LHR group — 10.8 ± 0.9 points (p = 0.339). Laparoscopic and open hernia repair in injured patients did not differ in the frequency of intraoperative complications — 19.2 % and 15.8 %, respectively (p = 0.766). There we
腹部枪伤往往造成腹部脏器的严重损伤,并伴有腹膜炎,进一步发展各种并发症(吻合口漏、脓肿形成、反复出血等),需要反复手术干预,从而形成术后腹疝。腹侧疝的手术治疗具有挑战性,因为腹腔严重粘连(与损伤后的时间和最后一次手术干预无关),前腹壁肌腱膜成分的巨大缺陷难以关闭,前腹壁挛缩,术后出现腹膜间室综合征。因此,对于术后腹疝的最佳手术治疗方法仍存在争议。目的:比较分析开放式和视频辅助腹腔镜手术治疗腹部枪伤后腹疝的最佳手术策略。材料和方法。我们分析了45例腹部枪伤术后腹部疝的手术治疗。2014 - 2021年在南部地区(敖德萨)军事医学临床中心治疗;其中32例为穿透性枪伤,13例为腹部闭合性枪伤,腹部脏器损伤。腹部器官1次手术者占66.7%,2次手术者占22.2%,3次手术者占6.7%,5次手术者占4.4%。根据SWE分类确定疝口的大小和复发风险的严重程度:W1(疝口宽度达4cm)占28.9%,W2(从4到10 cm)占44.4%,W3(超过10 cm)占26.7%。行腹腔镜疝修补术(LHR)的患者(IPOM - Plus法17例,sIPOM法2例)属于LHR组(n = 19)。将行开放性疝修补术(OHR)的患者(IPOM - Plus法7例,亚埋法11例,覆盖法8例)加入OHR组(n = 26)。两组患者在年龄、枪伤性质、疝修补前手术次数、疝参数等方面均无统计学差异(p > 0.05)。枪伤后的术后疝与明显的腹腔粘连有关。腹膜粘连指数平均值平均为11.7±0.7分(5 ~ 23分),组间差异无统计学意义:OHR组为12.4±0.9分,LHR组为10.8±0.9分(p = 0.339)。腹腔镜疝修补术与开放式疝修补术在术中并发症发生率上无差异,分别为19.2%和15.8% (p = 0.766)。术后并发症较少(10.5%比38.5%,p = 0.036),手术时间较短(79.5±6.8 min比105.9±4.7 min, p = 0.002),住院日较短(8.6±0.4 d比10.8±0.5 d, p = 0.004),术后2天内需要麻醉镇痛的患者较少(p < 0.05)。随访1年,各组无疝复发及粘连征象。在腹部枪伤术后腹疝的结构中,开放性枪伤患者居多,占71.1% (χ = 0.007)。其中,合并、多发伤患者占65.6%,单发伤患者占34.4% (χ = 0.112);33.3%的患者在疝修补前需要进行一次以上手术。腹腔镜IPOM - Plus技术应被认为是治疗腹部枪伤后疝的首选手术。同时,对于前腹壁广泛的美容缺陷,开放手术是可取的,特别是IPOM - Plus技术。如果这在技术上是不可能的,则应采用无张力异体疝成形术进行下疝或疝修补术。
{"title":"Ventral hernia repair surgery after abdominal gunshot wound","authors":"I. Khomenko, V. Shapovalov, O. Herasymenko, R. Gybalo, R. Yenin","doi":"10.30978/gs-2022-2-29","DOIUrl":"https://doi.org/10.30978/gs-2022-2-29","url":null,"abstract":"Gunshot wounds to the abdomen frequently result in significant damage to the abdominal organs, which is accompanied by peritonitis and the further development of different complications (anastomotic leakage, formation of abscesses, repeated bleeding, etc.), which require repeated surgical interventions that contribute to the formation of postoperative ventral hernias. The surgical management of ventral hernias is challenging due to severe adhesion in the abdominal cavity (irrespective of the time period since the injury and the last surgical interventions), the difficulties in closing massive defects of the muscle‑aponeurotic component of the anterior abdominal wall, contracture of the anterior abdominal wall, and the development of the abdominal compartment syndrome in the postoperative period. As a result, there is still some debate over the best surgical treatment for postoperative ventral hernias.\u0000Objective — to carry out a comparative analysis of open and video‑assisted laparoscopic operations for the selection of the most optimal surgical strategy for the management of ventral hernias after gunshot wounds to the abdomen.\u0000Materials and methods. We analyzed the surgical treatment of 45 wounded patients with postoperative ventral hernias that developed after operations for abdominal gunshot wounds. The patients were treated at the Military Medical Clinical Center of the Southern Region (Odesa) from 2014 to 2021; 32 of them had penetrating gunshot wounds, and 13 patients had a closed gunshot wound to the abdomen with injuries to the abdominal organs. 66.7 % of those injured had one operation on their abdominal organs, 22.2 % had two operations, 6.7 % had three operations, and 4.4 % had five operations. The size of the hernia orifices and severity of recurrence risk were determined according to the SWE classification: W1 (width of the hernia orifices up to 4 cm) — 28.9 %, W2 (from 4 to 10 cm) — 44.4 %, and W3 (over 10 cm) — 26.7 % of patients. The patients who had laparoscopic hernia repair (LHR) (IPOM‑Plus method — 17 patients, sIPOM — 2 patients) belonged to the LHR group (n = 19). The patients who had open hernia repair (OHR) (IPOM‑Plus method — 7 patients, sublay technique — 11 patients, onlay technique — 8 patients) were added to the OHR group (n = 26). The patients of both groups did not statistically differ by age, nature of a gunshot injury, number of operations before hernia repair, or hernia parameters (all p > 0.05).\u0000Results. Postoperative hernias after gunshot wounds are associated with pronounced adhesions in the abdominal cavity. The mean value of the peritoneal adhesion index averaged 11.7 ± 0.7 points (from 5 to 23 points) and did not statistically differ between groups: in the OHR group — 12.4 ± 0.9 points, in the LHR group — 10.8 ± 0.9 points (p = 0.339). Laparoscopic and open hernia repair in injured patients did not differ in the frequency of intraoperative complications — 19.2 % and 15.8 %, respectively (p = 0.766). There we","PeriodicalId":12661,"journal":{"name":"General Surgery","volume":"24 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81709365","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anatomy-based treatment strategy for abdominal and retroperitoneal cystic lymphatic malformations in children 儿童腹腔及腹膜后囊性淋巴畸形的解剖学治疗策略
Pub Date : 2022-12-30 DOI: 10.30978/gs-2022-2-39
D. Diehtiarova
Lymphatic malformations (LMs) are rare congenital benign malformations of the lymphatic system, consisting of fluid‑filled cysts or channels with unusual growth. The low incidence of LMs leads to a challenging differential diagnosis and a complicated choice of further treatment strategies. In this study, we analyzed our experience in the treatment of abdominal and retroperitoneal cystic LMs and proposed an anatomy‑based treatment strategy that could improve the treatment outcomes. Objective —  to prove that the anatomical localization of LM influences treatment effectiveness and should be taken into account when making treatment decisions. Materials and methods. Out of 240 pediatric patients who underwent treatment for cystic LMs at a single center from December 2012 to December 2020, 43 (19.1 %) were diagnosed with abdominal and retroperitoneal LMs. The follow‑up period was 3.50 ± 2.16 years. Results. Surgical resection of abdominal LMs without evident connection with cisterna chyli does not lead to a recurrence. Sclerotherapy is the best treatment option for retroperitoneal LMs. Diffuse mesentery affection can be successfully treated by sirolimus systemic therapy. According to a logistic regression model, initial choice of LM treatment without considering anatomical localization influences the risks of LM treatment failure (p = 0.000503). All patients in our study group received the following treatments: laparoscopic resections (n = 10, 23.2 %), videoassisted resections (n = 11, 25.5 %), laparotomy resections (n = 9, 20.9 %), sclerotherapy (n = 4, 9.3 %), sclerotherapy and surgery combination (n = 1, 2.3 %), sirolimus systemic therapy (n = 2, 4.6 %), and splenectomy (n = 1, 2.3 %). Six (13.4 %) patients are under dynamic observation. The recommended technique for treating abdominal LMs produced excellent outcomes in 35 (81.4 %) patients, good outcomes in 5 (11.6 %) patients, satisfactory outcomes in 2 (4.7 %) patients, and unsatisfactory outcomes in 1 (2.3 %) patient. Conclusions. Treatment strategies for abdominal and retroperitoneal LMs should be based on their anatomical localization. Retroperitoneal localization indicates a high risk of surgical treatment failure (p = 0.0006).  
淋巴畸形(LMs)是一种罕见的先天性淋巴系统良性畸形,由异常生长的充满液体的囊肿或通道组成。LMs的低发病率导致了鉴别诊断的挑战和进一步治疗策略的复杂选择。在本研究中,我们分析了我们治疗腹部和腹膜后囊性LMs的经验,并提出了一种基于解剖学的治疗策略,可以改善治疗效果。目的:证明LM的解剖定位影响治疗效果,在制定治疗决策时应予以考虑。材料和方法。2012年12月至2020年12月,在同一中心接受囊性LMs治疗的240名儿童患者中,43名(19.1%)被诊断为腹部和腹膜后LMs。随访时间为3.50±2.16年。结果。手术切除与乳糜池无明显联系的腹部LMs不会导致复发。硬化疗法是腹膜后LMs的最佳治疗选择。弥漫性肠系膜病变可通过西罗莫司全身治疗成功。根据logistic回归模型,不考虑解剖定位的LM治疗初始选择影响LM治疗失败的风险(p = 0.000503)。本研究组所有患者均接受了以下治疗:腹腔镜切除(n = 10, 23.2%)、视频辅助切除(n = 11, 25.5%)、剖腹切除(n = 9, 20.9%)、硬化治疗(n = 4, 9.3%)、硬化治疗和手术联合(n = 1, 2.3%)、西罗莫司全身治疗(n = 2, 4.6%)和脾切除术(n = 1, 2.3%)。动态观察6例(13.4%)。推荐的治疗腹部LMs的技术在35例(81.4%)患者中获得了良好的结果,5例(11.6%)患者获得了良好的结果,2例(4.7%)患者获得了满意的结果,1例(2.3%)患者获得了不满意的结果。结论。腹部和腹膜后LMs的治疗策略应基于其解剖定位。腹膜后定位提示手术治疗失败的高风险(p = 0.0006)。
{"title":"Anatomy-based treatment strategy for abdominal and retroperitoneal cystic lymphatic malformations in children","authors":"D. Diehtiarova","doi":"10.30978/gs-2022-2-39","DOIUrl":"https://doi.org/10.30978/gs-2022-2-39","url":null,"abstract":"Lymphatic malformations (LMs) are rare congenital benign malformations of the lymphatic system, consisting of fluid‑filled cysts or channels with unusual growth. The low incidence of LMs leads to a challenging differential diagnosis and a complicated choice of further treatment strategies. In this study, we analyzed our experience in the treatment of abdominal and retroperitoneal cystic LMs and proposed an anatomy‑based treatment strategy that could improve the treatment outcomes. \u0000Objective —  to prove that the anatomical localization of LM influences treatment effectiveness and should be taken into account when making treatment decisions. \u0000Materials and methods. Out of 240 pediatric patients who underwent treatment for cystic LMs at a single center from December 2012 to December 2020, 43 (19.1 %) were diagnosed with abdominal and retroperitoneal LMs. The follow‑up period was 3.50 ± 2.16 years. \u0000Results. Surgical resection of abdominal LMs without evident connection with cisterna chyli does not lead to a recurrence. Sclerotherapy is the best treatment option for retroperitoneal LMs. Diffuse mesentery affection can be successfully treated by sirolimus systemic therapy. According to a logistic regression model, initial choice of LM treatment without considering anatomical localization influences the risks of LM treatment failure (p = 0.000503). All patients in our study group received the following treatments: laparoscopic resections (n = 10, 23.2 %), videoassisted resections (n = 11, 25.5 %), laparotomy resections (n = 9, 20.9 %), sclerotherapy (n = 4, 9.3 %), sclerotherapy and surgery combination (n = 1, 2.3 %), sirolimus systemic therapy (n = 2, 4.6 %), and splenectomy (n = 1, 2.3 %). Six (13.4 %) patients are under dynamic observation. The recommended technique for treating abdominal LMs produced excellent outcomes in 35 (81.4 %) patients, good outcomes in 5 (11.6 %) patients, satisfactory outcomes in 2 (4.7 %) patients, and unsatisfactory outcomes in 1 (2.3 %) patient. \u0000Conclusions. Treatment strategies for abdominal and retroperitoneal LMs should be based on their anatomical localization. Retroperitoneal localization indicates a high risk of surgical treatment failure (p = 0.0006). \u0000 ","PeriodicalId":12661,"journal":{"name":"General Surgery","volume":"13 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89267771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predicting lethal outcome risks in patients with craniomaxillofacial trauma and polytrauma by the ISS and NISS 通过ISS和NISS预测颅颌面创伤和多发创伤患者的致命结局风险
Pub Date : 2022-12-30 DOI: 10.30978/gs-2022-2-13
I. Shumynskyi, M. Sabadosh, V. Gurianov, A. Kopchak
Multiple papers reveal no reliable difference between early and delayed maxillofacial injuries treatment in postoperative complications in patients with craniomaxillofacial trauma and polytrauma. A choice factor of the treatment tactics is the lethal outcome risk, as well as the lethal outcome prognosis. In order to objectivize the severity of trauma authors suggested the assessment scores which represent patient’s condition severity in points and provide lethal outcome risk estimation, — Injury Severity Score (ISS) and New Injury Severity Score (NISS), each with advantages and disadvantages of prognosing the lethal outcome. Though, the data on its preciseness and informativeness regarding patients with combined craniomaxillofacial trauma are limited, and the results, obtained from various authors, seem to be controversial. Objective — to identify and compare the threshold (critical) values of the ISS and NISS assessment scales which predict the lethal outcome risks in patients with craniomaxillofacial trauma and polytrauma. Materials and methods. During 2016 — 2019 years 503 patients were treated due to maxillofacial traumas and associated injuries. Patients age ranged from 18 till 91 years, (average age — 30.5 years). There was a male predominance in the sample (84.3 %). Facial bone fractures occurred in 70 % of cases (352 patients). Mainly after assaults (44 %), falls (20 %) and motor‑vehicle accidents (16 %). The other etiological factors included occupational traumas (0.5 %), sport traumas (1 %) and unknown aetiology traumas. The study evaluated patients with facial and concomitant injuries, who received multidisciplinary treatment in a specialized trauma hospital. Values of Injury Severity Score and New Injury Severity Score were statistically analyzed to evaluate effectiveness in prognosing lethal outcome risks. Results. Mortality in the sample was 3 % (15 patients). With the optimum cut‑off value of ISS > 24, lethal outcome prognosis model sensitivity yields 93.3 %, specificity — 91.4 %. With the optimum cut‑off value NISS > 36, the lethal outcome prognosis sensitivity yields 86.7 %, its specificity 92.4 %. Conclusions. ISS and NISS demonstrate similar effectiveness in prognosing lethal outcome risks. The difference of area under the curve of both trauma severity estimation methods is not statistically significant (р = 0.651). Both indicators could be used in daily practice in specialized hospitals to assess the patient’s condition and determine priority of treatment steps.
多篇论文显示,颅颌面外伤和多发外伤患者术后并发症的早期和延迟颌面损伤治疗没有可靠的差异。治疗策略的选择因素是致死性结局风险,以及致死性结局预后。为了客观评价创伤的严重程度,作者提出了代表患者病情严重程度并提供致死性结局风险估计的评估评分——损伤严重程度评分(ISS)和新损伤严重程度评分(NISS),它们各自具有预测致死性结局的优点和缺点。然而,关于颅颌面联合创伤患者的准确性和信息量的数据是有限的,并且从不同作者获得的结果似乎是有争议的。目的-识别和比较预测颅颌面外伤和多发外伤患者致命结局风险的ISS和NISS评估量表的阈值(临界值)。材料和方法。2016 - 2019年间,503例患者因颌面部创伤及相关损伤接受了治疗。患者年龄18 ~ 91岁(平均年龄- 30.5岁)。样本中存在男性优势(84.3%)。352例(70%)发生面骨骨折。主要发生在袭击(44%)、跌倒(20%)和机动车事故(16%)之后。其他病因包括职业创伤(0.5%)、运动创伤(1%)和未知病因。该研究评估了在创伤专科医院接受多学科治疗的面部及伴发损伤患者。对损伤严重程度评分(Injury Severity Score)和新损伤严重程度评分(New Injury Severity Score)的值进行统计分析,以评估对预后致死结局风险的有效性。结果。样本死亡率为3%(15例)。当最佳截断值ISS > 24时,致死性预后模型敏感性为93.3%,特异性为91.4%。当最佳截断值NISS > 36时,致死性预后敏感性为86.7%,特异性为92.4%。结论。ISS和NISS在预测致命结局风险方面显示出相似的有效性。两种创伤严重程度估计方法的曲线下面积差异无统计学意义(χ = 0.651)。这两项指标均可用于专科医院的日常实践中,以评估患者的病情并确定优先治疗步骤。
{"title":"Predicting lethal outcome risks in patients with craniomaxillofacial trauma and polytrauma by the ISS and NISS","authors":"I. Shumynskyi, M. Sabadosh, V. Gurianov, A. Kopchak","doi":"10.30978/gs-2022-2-13","DOIUrl":"https://doi.org/10.30978/gs-2022-2-13","url":null,"abstract":"Multiple papers reveal no reliable difference between early and delayed maxillofacial injuries treatment in postoperative complications in patients with craniomaxillofacial trauma and polytrauma. A choice factor of the treatment tactics is the lethal outcome risk, as well as the lethal outcome prognosis. In order to objectivize the severity of trauma authors suggested the assessment scores which represent patient’s condition severity in points and provide lethal outcome risk estimation, — Injury Severity Score (ISS) and New Injury Severity Score (NISS), each with advantages and disadvantages of prognosing the lethal outcome. Though, the data on its preciseness and informativeness regarding patients with combined craniomaxillofacial trauma are limited, and the results, obtained from various authors, seem to be controversial. \u0000Objective — to identify and compare the threshold (critical) values of the ISS and NISS assessment scales which predict the lethal outcome risks in patients with craniomaxillofacial trauma and polytrauma. \u0000Materials and methods. During 2016 — 2019 years 503 patients were treated due to maxillofacial traumas and associated injuries. Patients age ranged from 18 till 91 years, (average age — 30.5 years). There was a male predominance in the sample (84.3 %). Facial bone fractures occurred in 70 % of cases (352 patients). Mainly after assaults (44 %), falls (20 %) and motor‑vehicle accidents (16 %). The other etiological factors included occupational traumas (0.5 %), sport traumas (1 %) and unknown aetiology traumas. The study evaluated patients with facial and concomitant injuries, who received multidisciplinary treatment in a specialized trauma hospital. Values of Injury Severity Score and New Injury Severity Score were statistically analyzed to evaluate effectiveness in prognosing lethal outcome risks. \u0000Results. Mortality in the sample was 3 % (15 patients). With the optimum cut‑off value of ISS > 24, lethal outcome prognosis model sensitivity yields 93.3 %, specificity — 91.4 %. With the optimum cut‑off value NISS > 36, the lethal outcome prognosis sensitivity yields 86.7 %, its specificity 92.4 %. \u0000Conclusions. ISS and NISS demonstrate similar effectiveness in prognosing lethal outcome risks. The difference of area under the curve of both trauma severity estimation methods is not statistically significant (р = 0.651). Both indicators could be used in daily practice in specialized hospitals to assess the patient’s condition and determine priority of treatment steps.","PeriodicalId":12661,"journal":{"name":"General Surgery","volume":"32 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87967805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Case of gunshot injury to the liver by a hand-made modified sniper bullet: organ-preserving surgical management with damage control tactics and transpapillary biliary decompression 自制改良狙击子弹致肝脏枪伤1例:保留器官的手术治疗及损伤控制策略及经毛细血管胆道减压术
Pub Date : 2022-12-30 DOI: 10.30978/gs-2022-2-64
I. Khomenko, I. Tsema, K. Humeniuk, V. Slobodianyk, D. Rahushyn
Combat penetrating gunshot injuries are frequently associated with damage to the liver. A bile leak and an external biliary fistula (EBF) are typical complications. Biliary decompression is commonly applied for the management of EBF. Furthermore, there is insufficient data available regarding the characteristics of combat trauma and its management in the context of ongoing hybrid warfare in East Ukraine. A 23­year­old male was admitted with a thoracoabdominal penetrating gunshot wound (GSW) that was caused by a high­energy multiple metal projectile (a fragmented sniper bullet). Damage control tactics was applied at all 4 levels of military medical care. Endoscopic retrograde cholangiopancreatography (ERCP), endoscopic sphincterotomy, and placement of a biliary stent were used for evaluation and biliary decompression. Stent occlusion was treated with stent replacement and scheduled ERCP. Partial EBF was diagnosed based on the primary wound defect of the liver and was closed without surgical intervention on the 34th day after injury. Acute cholecystitis was associated with ERCP and was managed with cholecystostomy. The combination of operative and nonoperative techniques for the management of the combat GSW to the liver is effective, along with the application of damage control tactics. Scheduled ERCP is effective for the management of EBF, so liver resection can be avoided. The transpapillary intervention with stent placement was successfully used for biliary decompression. Early post­traumatic stent occlusion can be diagnosed and effectively managed by scheduled ERCP as well as stent replacement with a large­diameter stent inserted as close as possible to the site of bile leak.  
战斗穿透性枪伤通常与肝脏损伤有关。胆漏和胆外瘘是典型的并发症。胆道减压是治疗EBF的常用方法。此外,在东乌克兰正在进行的混合战争背景下,关于战斗创伤的特征及其管理的现有数据不足。一名23岁男性因胸腹穿透性枪伤(GSW)入院,枪伤是由高能多金属弹丸(一颗破碎的狙击子弹)造成的。在所有4级军事医疗保健中都采用了损害控制战术。内镜下逆行胆管造影(ERCP),内镜下括约肌切开术和放置胆道支架用于评估和胆道减压。支架闭塞通过支架置换术和计划的ERCP治疗。根据肝脏原发创面缺损诊断为部分EBF,伤后第34天无手术治疗。急性胆囊炎与ERCP相关,采用胆囊造口术治疗。手术与非手术技术相结合,结合损伤控制策略,有效地处理了肝脏的战斗枪伤。计划ERCP对EBF的治疗是有效的,因此可以避免肝切除术。经冠状动脉介入联合支架置入术成功用于胆道减压。早期创伤后支架闭塞可通过计划的ERCP以及在尽可能靠近胆漏部位的位置置放大直径支架来诊断和有效治疗。
{"title":"Case of gunshot injury to the liver by a hand-made modified sniper bullet: organ-preserving surgical management with damage control tactics and transpapillary biliary decompression","authors":"I. Khomenko, I. Tsema, K. Humeniuk, V. Slobodianyk, D. Rahushyn","doi":"10.30978/gs-2022-2-64","DOIUrl":"https://doi.org/10.30978/gs-2022-2-64","url":null,"abstract":"Combat penetrating gunshot injuries are frequently associated with damage to the liver. A bile leak and an external biliary fistula (EBF) are typical complications. Biliary decompression is commonly applied for the management of EBF. Furthermore, there is insufficient data available regarding the characteristics of combat trauma and its management in the context of ongoing hybrid warfare in East Ukraine. \u0000A 23­year­old male was admitted with a thoracoabdominal penetrating gunshot wound (GSW) that was caused by a high­energy multiple metal projectile (a fragmented sniper bullet). Damage control tactics was applied at all 4 levels of military medical care. Endoscopic retrograde cholangiopancreatography (ERCP), endoscopic sphincterotomy, and placement of a biliary stent were used for evaluation and biliary decompression. Stent occlusion was treated with stent replacement and scheduled ERCP. Partial EBF was diagnosed based on the primary wound defect of the liver and was closed without surgical intervention on the 34th day after injury. Acute cholecystitis was associated with ERCP and was managed with cholecystostomy. \u0000The combination of operative and nonoperative techniques for the management of the combat GSW to the liver is effective, along with the application of damage control tactics. Scheduled ERCP is effective for the management of EBF, so liver resection can be avoided. The transpapillary intervention with stent placement was successfully used for biliary decompression. Early post­traumatic stent occlusion can be diagnosed and effectively managed by scheduled ERCP as well as stent replacement with a large­diameter stent inserted as close as possible to the site of bile leak. \u0000 ","PeriodicalId":12661,"journal":{"name":"General Surgery","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89759824","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pro-inflammatory effects of placebo neurosurgery in rats: age-related features 大鼠神经外科安慰剂的促炎作用:与年龄相关的特征
Pub Date : 2022-12-30 DOI: 10.30978/gs-2022-2-56
A. Nefodova, M. Rudyk, M. Pasichnichenko, R. Dovhyi, T. Dovbynchuk, G. Tolstanova, L. Skivka
Alzheimer’s disease (AD) and Parkinson’s disease (PD) are the two most prevalent neurodegenerative diseases, affecting millions of people globally and causing significant disability and mortality. Animal models are the final step in completing preclinical studies and the most appropriate approach for gaining a thorough understanding of disease pathophysiology. Modeling of idiopathic AD and PD in rodents requires stereotactic injections of disease‑triggering substances. The placebo surgery group is an integral component of the design of these experiments in order to diminish study bias as a result of animal stress and non‑specific surgical impact. Inflammation is the most commonly reported non‑specific post‑surgery phenomenon, which can manifest in different ways in animals of different ages used in these experiments.Objective — to compare the long‑term pro‑inflammatory effects of placebo surgery, commonly employed for PD and AD modeling, in rats of different ages.Materials and methods. Adult male Wistar rats aged 4 and 14 months were used in the study. The placebo surgery consisted of a stereotactic unilateral intracerebral infusion of buffer solution. Before the placebo surgery, animals were anaesthetized using ketamine or xylazine administered intraperitoneally. Intact animals of both ages were used as a control. The evaluation of pro‑inflammatory effects of placebo surgery was conducted using biomarkers of local and systemic inflammation: metabolic polarization of phagocytes (microglia, peripheral blood cells), C‑reactive protein (CRP) plasma level, and systemic inflammation indexes calculated from the hemogram study.Results. In young lesioned animals, a pronounced pro‑inflammatory functional shift of microglia and signs of the resolution of systemic inflammation (an anti‑inflammatory skew of circulating phagocyte metabolism as compared to age‑matched intact controls) were observed in the long term after the placebo neurosurgery. In old intact animals, hematological and immunological markers of low‑grade systemic inflammation were observed. In lesioned old rats, residual neuroinflammation along with pronounced systemic inflammatory responses (leukocytosis, substantially increased SIRI and SII values, pro‑inflammatory metabolic shift of peripheral blood phagocytes as compared to age‑matched intact controls) were registered.Conclusions. The effects of placebo neurosurgical manipulations in rats depend on age. Meta‑inflammation inherent to aged rats is aggravated by non‑specific post‑surgery inflammation, leading to pronounced, persistent systemic inflammatory responses. 
阿尔茨海默病(AD)和帕金森病(PD)是两种最常见的神经退行性疾病,影响着全球数百万人,并造成严重的残疾和死亡。动物模型是完成临床前研究的最后一步,也是深入了解疾病病理生理的最合适方法。在啮齿类动物中建立特发性AD和PD模型需要立体定向注射疾病触发物质。安慰剂手术组是这些实验设计的一个组成部分,以减少由于动物应激和非特异性手术影响而导致的研究偏差。炎症是最常见的非特异性手术后现象,在这些实验中使用的不同年龄的动物中可以以不同的方式表现出来。目的:比较不同年龄大鼠PD和AD模型中常用的安慰剂手术的长期促炎作用。材料和方法。研究对象为4月龄和14月龄成年雄性Wistar大鼠。安慰剂手术包括立体定向单侧脑内注入缓冲溶液。在安慰剂手术之前,动物被用氯胺酮或噻嗪腹腔麻醉。两个年龄的完整动物作为对照。使用局部和全身炎症的生物标志物:吞噬细胞(小胶质细胞、外周血细胞)的代谢极化、C反应蛋白(CRP)血浆水平和血象研究计算的全身炎症指标来评估安慰剂手术的促炎作用。在年轻的病变动物中,在安慰剂神经外科手术后长期观察到小胶质细胞明显的促炎功能转移和全身炎症消退的迹象(与年龄匹配的完整对照相比,循环吞噬细胞代谢的抗炎倾斜)。在年老的完整动物中,观察到低度全身性炎症的血液学和免疫学标志物。在受损的老年大鼠中,残留的神经炎症伴随着明显的全身炎症反应(白细胞增多,SIRI和SII值显著增加,与年龄匹配的完整对照组相比,外周血吞噬细胞的促炎代谢改变)被记录下来。安慰剂神经外科操作对大鼠的影响取决于年龄。老年大鼠固有的元性炎症会因非特异性手术后炎症而加重,导致明显的、持续的全身炎症反应。
{"title":"Pro-inflammatory effects of placebo neurosurgery in rats: age-related features","authors":"A. Nefodova, M. Rudyk, M. Pasichnichenko, R. Dovhyi, T. Dovbynchuk, G. Tolstanova, L. Skivka","doi":"10.30978/gs-2022-2-56","DOIUrl":"https://doi.org/10.30978/gs-2022-2-56","url":null,"abstract":"Alzheimer’s disease (AD) and Parkinson’s disease (PD) are the two most prevalent neurodegenerative diseases, affecting millions of people globally and causing significant disability and mortality. Animal models are the final step in completing preclinical studies and the most appropriate approach for gaining a thorough understanding of disease pathophysiology. Modeling of idiopathic AD and PD in rodents requires stereotactic injections of disease‑triggering substances. The placebo surgery group is an integral component of the design of these experiments in order to diminish study bias as a result of animal stress and non‑specific surgical impact. Inflammation is the most commonly reported non‑specific post‑surgery phenomenon, which can manifest in different ways in animals of different ages used in these experiments.\u0000Objective — to compare the long‑term pro‑inflammatory effects of placebo surgery, commonly employed for PD and AD modeling, in rats of different ages.\u0000Materials and methods. Adult male Wistar rats aged 4 and 14 months were used in the study. The placebo surgery consisted of a stereotactic unilateral intracerebral infusion of buffer solution. Before the placebo surgery, animals were anaesthetized using ketamine or xylazine administered intraperitoneally. Intact animals of both ages were used as a control. The evaluation of pro‑inflammatory effects of placebo surgery was conducted using biomarkers of local and systemic inflammation: metabolic polarization of phagocytes (microglia, peripheral blood cells), C‑reactive protein (CRP) plasma level, and systemic inflammation indexes calculated from the hemogram study.\u0000Results. In young lesioned animals, a pronounced pro‑inflammatory functional shift of microglia and signs of the resolution of systemic inflammation (an anti‑inflammatory skew of circulating phagocyte metabolism as compared to age‑matched intact controls) were observed in the long term after the placebo neurosurgery. In old intact animals, hematological and immunological markers of low‑grade systemic inflammation were observed. In lesioned old rats, residual neuroinflammation along with pronounced systemic inflammatory responses (leukocytosis, substantially increased SIRI and SII values, pro‑inflammatory metabolic shift of peripheral blood phagocytes as compared to age‑matched intact controls) were registered.\u0000Conclusions. The effects of placebo neurosurgical manipulations in rats depend on age. Meta‑inflammation inherent to aged rats is aggravated by non‑specific post‑surgery inflammation, leading to pronounced, persistent systemic inflammatory responses.\u0000 ","PeriodicalId":12661,"journal":{"name":"General Surgery","volume":"337 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75932381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Professor Oleksiy Petrovych Krymov. An outline of the professional and scientific path of an outstanding surgeon 奥莱克西·彼得罗维奇·克里莫夫教授。一个杰出外科医生的专业和科学之路的概要
Pub Date : 2022-12-30 DOI: 10.30978/gs-2022-2-6
L. Zavernyĭ, T. Tarasiuk, Y. Tsiura, M. Kryvopustov
The article highlights the professional and scientific path of Professor Oleksiy Petrovych Krymov — professor of surgery and head of the Department of Faculty Surgery of the Kyiv Medical Institute.  
文章重点介绍了基辅医学研究所外科教授兼外科系主任奥列克西·彼得罗维奇·克里莫夫教授的专业和科学道路。
{"title":"Professor Oleksiy Petrovych Krymov. An outline of the professional and scientific path of an outstanding surgeon","authors":"L. Zavernyĭ, T. Tarasiuk, Y. Tsiura, M. Kryvopustov","doi":"10.30978/gs-2022-2-6","DOIUrl":"https://doi.org/10.30978/gs-2022-2-6","url":null,"abstract":"The article highlights the professional and scientific path of Professor Oleksiy Petrovych Krymov — professor of surgery and head of the Department of Faculty Surgery of the Kyiv Medical Institute. \u0000 ","PeriodicalId":12661,"journal":{"name":"General Surgery","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90220225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pembrolizumab as an immunotherapy drug in the treatment of a patient with recurrent (unresectable) cancer of the lower lip 派姆单抗作为一种免疫治疗药物用于治疗复发性(不可切除)下唇癌患者
Pub Date : 2022-12-30 DOI: 10.30978/gs-2022-2-75
L. Markulan, L. M. Makarevych
Advances in immunotherapy have changed approaches to the treatment of recurrent and/or metastatic head and neck squamous cell carcinoma (R/M HNSCC). The US Food and Drug Administration (the FDA) has approved both pembrolizumab monotherapy for first‑line treatment of the tumours expressing the programmed cell death receptor‑1 (PD‑L1; combined positive score of ≥ 1) in patients with R/M HNSCC and pembrolizumab administration in combination with platinum and fluorouracil regardless of the level of PD‑L1 expression. Pembrolizumab is a humanized monoclonal antibody class drug that activates the anti‑tumour immune response. Objective — to present treatment outcomes for recurrent (unresectable) cancer of the lower lip that was treated using a pembrolizumab monotherapy regimen. Patient H., born in 1968, received a 20‑month combined therapy for cancer of the lower lip. He had radical surgical removal of the primary tumour and two surgical resections of metastases, as well as courses of both remote gamma‑therapy and polychemotherapy. Nevertheless, the disease progressed from T2N0M0 to T4N1M0. In the area of the chin and right cheek, the patient developed a defect of the skin and subcutaneous tissue measuring 18 ´ 10 cm with purulent‑necrotic margins and an external fistula of the oral cavity. He was also bothered by unbearable pain in the area of the tumour and an unpleasant odour from the mouth and from the tumour. The patient was prescribed immunotherapy with pembrolizumab since an immunohistochemical examination revealed an RD‑L1‑positive tumour. One year after the start of immunotherapy, which included 17 courses of cancer treatment, the wound healed and the patient’s quality of life significantly improved. No adverse reactions were observed during immunotherapy. Computed tomography revealed a 25 x 15 mm nodule at the level of the lower jaw on the right and a lymph node of about 10 mm in diameter in the area of the lower parts of the right parotid salivary gland. Distant metastases were not detected. Currently, immunotherapy is ongoing. The issue of surgical removal of pathological formations is under consideration. This case demonstrates the positive outcomes of a pembrolizumab monotherapy regimen in a patient with R/M HNSCC.  
免疫疗法的进步已经改变了治疗复发性和/或转移性头颈部鳞状细胞癌(R/M HNSCC)的方法。美国食品和药物管理局(FDA)已批准pembrolizumab单药治疗用于表达程序性细胞死亡受体- 1 (PD - L1;无论PD - L1表达水平如何,R/M型HNSCC患者和派姆单抗联合铂和氟尿嘧啶给药的联合阳性评分≥1)。Pembrolizumab是一种激活抗肿瘤免疫反应的人源化单克隆抗体类药物。目的:介绍使用派姆单抗单药治疗的复发性(不可切除)下唇癌的治疗结果。患者H出生于1968年,接受了为期20个月的下唇癌联合治疗。他接受了原发肿瘤的根治性手术切除和两次转移性手术切除,并接受了远程伽玛治疗和多重化疗。然而,疾病从T2N0M0发展到T4N1M0。在下巴和右脸颊区域,患者出现皮肤和皮下组织缺损,尺寸为18´10 cm,伴有化脓性坏死边缘和口腔外瘘。他还被肿瘤区域难以忍受的疼痛和口腔和肿瘤发出的难闻气味所困扰。由于免疫组化检查显示为RD - L1阳性肿瘤,患者接受了派姆单抗免疫治疗。免疫治疗包括17个疗程的癌症治疗,一年后伤口愈合,患者的生活质量显著改善。免疫治疗期间未见不良反应。计算机断层扫描显示右侧下颌骨水平处有一个25 × 15mm的结节,右侧腮腺下端有一个直径约10mm的淋巴结。未发现远处转移。目前,免疫疗法正在进行中。手术切除病理组织的问题正在考虑之中。该病例证明了派姆单抗单药治疗R/M型HNSCC患者的积极结果。
{"title":"Pembrolizumab as an immunotherapy drug in the treatment of a patient with recurrent (unresectable) cancer of the lower lip","authors":"L. Markulan, L. M. Makarevych","doi":"10.30978/gs-2022-2-75","DOIUrl":"https://doi.org/10.30978/gs-2022-2-75","url":null,"abstract":"Advances in immunotherapy have changed approaches to the treatment of recurrent and/or metastatic head and neck squamous cell carcinoma (R/M HNSCC). The US Food and Drug Administration (the FDA) has approved both pembrolizumab monotherapy for first‑line treatment of the tumours expressing the programmed cell death receptor‑1 (PD‑L1; combined positive score of ≥ 1) in patients with R/M HNSCC and pembrolizumab administration in combination with platinum and fluorouracil regardless of the level of PD‑L1 expression. Pembrolizumab is a humanized monoclonal antibody class drug that activates the anti‑tumour immune response. \u0000Objective — to present treatment outcomes for recurrent (unresectable) cancer of the lower lip that was treated using a pembrolizumab monotherapy regimen. \u0000Patient H., born in 1968, received a 20‑month combined therapy for cancer of the lower lip. He had radical surgical removal of the primary tumour and two surgical resections of metastases, as well as courses of both remote gamma‑therapy and polychemotherapy. Nevertheless, the disease progressed from T2N0M0 to T4N1M0. In the area of the chin and right cheek, the patient developed a defect of the skin and subcutaneous tissue measuring 18 ´ 10 cm with purulent‑necrotic margins and an external fistula of the oral cavity. He was also bothered by unbearable pain in the area of the tumour and an unpleasant odour from the mouth and from the tumour. The patient was prescribed immunotherapy with pembrolizumab since an immunohistochemical examination revealed an RD‑L1‑positive tumour. One year after the start of immunotherapy, which included 17 courses of cancer treatment, the wound healed and the patient’s quality of life significantly improved. No adverse reactions were observed during immunotherapy. Computed tomography revealed a 25 x 15 mm nodule at the level of the lower jaw on the right and a lymph node of about 10 mm in diameter in the area of the lower parts of the right parotid salivary gland. Distant metastases were not detected. Currently, immunotherapy is ongoing. The issue of surgical removal of pathological formations is under consideration. \u0000This case demonstrates the positive outcomes of a pembrolizumab monotherapy regimen in a patient with R/M HNSCC. \u0000 ","PeriodicalId":12661,"journal":{"name":"General Surgery","volume":"2 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89703754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Chin augmentation with custom-made implants for microgenia treatment: a two-year follow-up 用定制植入体隆胸治疗下颌小畸形:两年随访
Pub Date : 2022-12-30 DOI: 10.30978/gs-2022-2-20
I. Donets, O. Panchuk, K. V. Galperin
Objective —  to determine the feasibility and effectiveness of using custom‑made and 3D‑printed mandibular implants in patients with microgenia, and to investigate their quality of life and satisfaction with aesthetic results during a two‑year follow‑up. Materials and methods. 21 patients participated in the study, with 14 (66.7 %) women and 7 (33.3 %) men. The average age of patients was 23.4 ± 2.3 years. All patients had signs of microgenia. In our study, a CT scan of the skull without contrast enhancement served as the primary diagnostic tool. Polyetheretherketonen (PEEK) was the material of choice for the implants. Results. Among the early postoperative complications were alterations to the sensation of the skin overlying the lower lip, which was restored within 1 — 2 months, and bruising, which had a tendency to spread to the neck. None of the patients had impaired motor innervation of the lower lip. Hematoma and wound suppuration were not detected either. One or two years after surgery, none of the patients had any delayed complications, including implant displacement, bone resorption in the lower jaw, decreased motor activity of the facial muscles, or altered sensation affecting the lower lip. Aesthetic results were assessed after the one‑year follow‑up. In a sample of 21 patients, the aesthetic outcome was excellent in 18 (85.7 %) patients and good in 3 (14.3 %) patients. No patients had bad aesthetic outcomes. Conclusions. The absence of delayed complications and the low risk of early complications, which in 71.4 % of patients only present as a temporary alteration to the sensation affecting the lower lip, indicate the safety of the suggested method. In all patients after mentoplasty with custom‑made implants, the physical and mental components of health improved statistically (with all values p < 0.05). Excellent aesthetic outcomes were observed in almost all patients (85.7 %) after mentoplasty with custom‑made implants.  
目的:确定在小牙畸形患者中使用定制和3D打印下颌种植体的可行性和有效性,并在两年的随访中调查他们的生活质量和对美学结果的满意度。材料和方法。21例患者参与了这项研究,其中女性14例(66.7%),男性7例(33.3%)。患者平均年龄23.4±2.3岁。所有患者均有小生殖器症的症状。在我们的研究中,没有增强对比的颅骨CT扫描作为主要的诊断工具。聚醚醚酮(PEEK)是种植体的首选材料。结果。术后早期并发症包括下唇皮肤感觉的改变,在1 - 2个月内恢复,以及瘀伤,有扩散到颈部的趋势。所有患者均无下唇运动神经受损。未见血肿、创面化脓。手术后1 - 2年,所有患者均未出现任何延迟性并发症,包括种植体移位、下颌骨吸收、面部肌肉运动活动减少或影响下唇的感觉改变。随访1年后评估美观效果。在21例患者的样本中,18例(85.7%)患者的美学结果为优,3例(14.3%)患者的美学结果为良。没有患者有不良的美学结果。结论。没有迟发性并发症和早期并发症的低风险,71.4%的患者仅表现为影响下唇的暂时感觉改变,表明该方法的安全性。在所有使用定制植入物的患者中,身体和精神健康成分均有统计学改善(均p < 0.05)。几乎所有患者(85.7%)在使用定制植入物进行脑洞成形术后均获得了良好的美学效果。
{"title":"Chin augmentation with custom-made implants for microgenia treatment: a two-year follow-up","authors":"I. Donets, O. Panchuk, K. V. Galperin","doi":"10.30978/gs-2022-2-20","DOIUrl":"https://doi.org/10.30978/gs-2022-2-20","url":null,"abstract":"Objective —  to determine the feasibility and effectiveness of using custom‑made and 3D‑printed mandibular implants in patients with microgenia, and to investigate their quality of life and satisfaction with aesthetic results during a two‑year follow‑up. \u0000Materials and methods. 21 patients participated in the study, with 14 (66.7 %) women and 7 (33.3 %) men. The average age of patients was 23.4 ± 2.3 years. All patients had signs of microgenia. In our study, a CT scan of the skull without contrast enhancement served as the primary diagnostic tool. Polyetheretherketonen (PEEK) was the material of choice for the implants. \u0000Results. Among the early postoperative complications were alterations to the sensation of the skin overlying the lower lip, which was restored within 1 — 2 months, and bruising, which had a tendency to spread to the neck. None of the patients had impaired motor innervation of the lower lip. Hematoma and wound suppuration were not detected either. One or two years after surgery, none of the patients had any delayed complications, including implant displacement, bone resorption in the lower jaw, decreased motor activity of the facial muscles, or altered sensation affecting the lower lip. Aesthetic results were assessed after the one‑year follow‑up. In a sample of 21 patients, the aesthetic outcome was excellent in 18 (85.7 %) patients and good in 3 (14.3 %) patients. No patients had bad aesthetic outcomes. \u0000Conclusions. The absence of delayed complications and the low risk of early complications, which in 71.4 % of patients only present as a temporary alteration to the sensation affecting the lower lip, indicate the safety of the suggested method. In all patients after mentoplasty with custom‑made implants, the physical and mental components of health improved statistically (with all values p < 0.05). Excellent aesthetic outcomes were observed in almost all patients (85.7 %) after mentoplasty with custom‑made implants. \u0000 ","PeriodicalId":12661,"journal":{"name":"General Surgery","volume":"26 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77002321","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-term follow-up results of pediatric liver transplants at our center 本中心小儿肝移植的长期随访结果
Pub Date : 2022-12-30 DOI: 10.30978/gs-2022-2-9
E. Karakaya, A. Akdur, H. E. Ayvazoğlu Soy, F. Özçay, S. Yıldırım, A. Sezgin, A. Torgay, G. Moray, M. Haberal
The only curative treatment for irreversible liver damage and chronic liver disease is liver transplantation (LT). Objectives: to determine long‑term follow‑up results, liver graft functions, and survival rates of pediatric LT recipients at our center. Materials and methods. All pediatric LT recipients performed between March 15, 1990 and August 11, 2022 were included in our study. Demographic characteristics, preoperative clinical features, LT indications, early and late postoperative complications, survival rates, and long‑term outcomes of pediatric LT recipients were evaluated. Results. Between March 15, 1990, and August 11, 2022, we performed 341 pediatric LTs (307 from living related donors and 34 from deceased donors). The most common indication for LT was biliary atresia. There were 3 hepatic vein, 5 portal vein, and 54 hepatic artery complications. Biliary stenosis was observed in 62 patients, and biliary leakage was observed in 54 patients. The overall five‑year survival rate was 84.1 %, and the 10‑year survival rate was 77.7 %. Conclusions. According to the long‑term outcomes of pediatric liver transplants performed in our center, liver transplantation is a successful treatment option for pediatric patients with end‑stage liver disease and irreversible liver damage. The patients’ survival rates are also satisfactory.  
治疗不可逆肝损伤和慢性肝病的唯一方法是肝移植(LT)。目的:确定本中心儿童肝移植受者的长期随访结果、肝移植功能和生存率。材料和方法。所有在1990年3月15日至2022年8月11日期间接受肝移植的儿科患者都被纳入我们的研究。评估儿童肝移植受者的人口统计学特征、术前临床特征、肝移植适应症、术后早期和晚期并发症、生存率和长期预后。结果。在1990年3月15日至2022年8月11日期间,我们进行了341例儿科LTs(307例来自在世的亲属供体,34例来自已故供体)。肝移植最常见的适应症是胆道闭锁。肝静脉3例,门静脉5例,肝动脉并发症54例。胆道狭窄62例,胆漏54例。总5年生存率为84.1%,10年生存率为77.7%。结论。根据本中心进行的儿童肝移植的长期结果,肝移植是终末期肝病和不可逆肝损害的儿童患者的成功治疗选择。患者的生存率也令人满意。
{"title":"Long-term follow-up results of pediatric liver transplants at our center","authors":"E. Karakaya, A. Akdur, H. E. Ayvazoğlu Soy, F. Özçay, S. Yıldırım, A. Sezgin, A. Torgay, G. Moray, M. Haberal","doi":"10.30978/gs-2022-2-9","DOIUrl":"https://doi.org/10.30978/gs-2022-2-9","url":null,"abstract":"The only curative treatment for irreversible liver damage and chronic liver disease is liver transplantation (LT). \u0000Objectives: to determine long‑term follow‑up results, liver graft functions, and survival rates of pediatric LT recipients at our center. \u0000Materials and methods. All pediatric LT recipients performed between March 15, 1990 and August 11, 2022 were included in our study. Demographic characteristics, preoperative clinical features, LT indications, early and late postoperative complications, survival rates, and long‑term outcomes of pediatric LT recipients were evaluated. \u0000Results. Between March 15, 1990, and August 11, 2022, we performed 341 pediatric LTs (307 from living related donors and 34 from deceased donors). The most common indication for LT was biliary atresia. There were 3 hepatic vein, 5 portal vein, and 54 hepatic artery complications. Biliary stenosis was observed in 62 patients, and biliary leakage was observed in 54 patients. The overall five‑year survival rate was 84.1 %, and the 10‑year survival rate was 77.7 %. \u0000Conclusions. According to the long‑term outcomes of pediatric liver transplants performed in our center, liver transplantation is a successful treatment option for pediatric patients with end‑stage liver disease and irreversible liver damage. The patients’ survival rates are also satisfactory. \u0000 ","PeriodicalId":12661,"journal":{"name":"General Surgery","volume":"33 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76998010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
General Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1